| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| 9.6 | 2.1 | 20 | 18.8 | 64.8 | 117.4 | 1.8 | - | - | - | 234.6 |
| 1 | 0.3 | 2.6 | 1.7 | 6.9 | 57.2 | 1 | - | - | - | 70.8 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| - |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 3 |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(R) | 4,119 | 98.3% | -1.72 | 1,253 | 99.4% |
| Optic-unspecified(R) | 68 | 1.6% | -3.28 | 7 | 0.6% |
| CentralBrain-unspecified | 3 | 0.1% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns Dm-DRA2 | % In | CV |
|---|---|---|---|---|---|
| R8d | 41 | HA | 85.4 | 41.1% | 0.7 |
| Cm11d (R) | 8 | ACh | 41.2 | 19.8% | 1.1 |
| Mi10 (R) | 24 | ACh | 15.8 | 7.6% | 0.8 |
| Cm11c (R) | 10 | ACh | 13.6 | 6.5% | 1.0 |
| Dm9 (R) | 20 | Glu | 8.6 | 4.1% | 1.2 |
| Cm11b (R) | 7 | ACh | 8.5 | 4.1% | 0.8 |
| Cm-DRA (R) | 3 | ACh | 4.7 | 2.3% | 0.5 |
| aMe4 (R) | 6 | ACh | 3.6 | 1.7% | 0.8 |
| R7_unclear | 9 | HA | 2.7 | 1.3% | 0.7 |
| R7d | 21 | HA | 2.5 | 1.2% | 0.8 |
| Cm4 (R) | 13 | Glu | 2.3 | 1.1% | 0.8 |
| Cm11a (R) | 7 | ACh | 2.2 | 1.1% | 0.8 |
| Cm5 (R) | 11 | GABA | 2.1 | 1.0% | 0.8 |
| Dm2 (R) | 26 | ACh | 1.8 | 0.9% | 0.3 |
| Dm-DRA1 (R) | 16 | Glu | 1.5 | 0.7% | 0.6 |
| Dm20 (R) | 10 | Glu | 1.2 | 0.6% | 0.6 |
| MeVPMe13 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| Mi15 (R) | 12 | ACh | 0.9 | 0.4% | 0.4 |
| R7p | 5 | HA | 0.8 | 0.4% | 0.6 |
| Dm-DRA2 (R) | 7 | Glu | 0.8 | 0.4% | 0.5 |
| MeVPMe13 (R) | 1 | ACh | 0.6 | 0.3% | 0.0 |
| MeVPLo2 (R) | 5 | ACh | 0.5 | 0.2% | 0.4 |
| TmY10 (R) | 1 | ACh | 0.4 | 0.2% | 0.0 |
| R8_unclear | 5 | HA | 0.4 | 0.2% | 0.3 |
| R8y | 2 | HA | 0.4 | 0.2% | 0.1 |
| Dm13 (R) | 5 | GABA | 0.3 | 0.2% | 0.3 |
| L3 (R) | 4 | ACh | 0.3 | 0.1% | 0.3 |
| MeVC22 (R) | 2 | Glu | 0.3 | 0.1% | 0.6 |
| L5 (R) | 2 | ACh | 0.2 | 0.1% | 0.0 |
| R7R8_unclear | 1 | HA | 0.2 | 0.1% | 0.0 |
| Dm11 (R) | 4 | Glu | 0.2 | 0.1% | 0.0 |
| aMe17b (R) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| Mi1 (R) | 2 | ACh | 0.2 | 0.1% | 0.3 |
| aMe17a (R) | 1 | unc | 0.2 | 0.1% | 0.0 |
| Mi4 (R) | 3 | GABA | 0.2 | 0.1% | 0.0 |
| R7y | 1 | HA | 0.1 | 0.1% | 0.0 |
| MeLo3b (R) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| Dm8b (R) | 1 | Glu | 0.1 | 0.1% | 0.0 |
| Mi16 (R) | 2 | GABA | 0.1 | 0.1% | 0.0 |
| Tm1 (R) | 2 | ACh | 0.1 | 0.1% | 0.0 |
| Dm4 (R) | 2 | Glu | 0.1 | 0.1% | 0.0 |
| MeVPMe3 (R) | 1 | Glu | 0.1 | 0.1% | 0.0 |
| Cm3 (R) | 2 | GABA | 0.1 | 0.1% | 0.0 |
| Cm22 (R) | 2 | GABA | 0.1 | 0.1% | 0.0 |
| Mi18 (R) | 2 | GABA | 0.1 | 0.1% | 0.0 |
| Dm8a (R) | 2 | Glu | 0.1 | 0.1% | 0.0 |
| MeTu3c (R) | 2 | ACh | 0.1 | 0.1% | 0.0 |
| Tm2 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVPMe12 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Tm3 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Lawf2 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Cm28 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeVP9 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| L1 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| aMe12 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Tm29 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Mi9 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeTu2b (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Tm5c (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| TmY9a (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Tm5Y (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Tm5a (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| downstream partner | # | NT | conns Dm-DRA2 | % Out | CV |
|---|---|---|---|---|---|
| Dm-DRA1 (R) | 26 | Glu | 59.5 | 24.3% | 0.3 |
| Dm2 (R) | 88 | ACh | 45.4 | 18.6% | 0.8 |
| Cm8 (R) | 30 | GABA | 16.2 | 6.6% | 0.7 |
| Dm9 (R) | 20 | Glu | 11.8 | 4.8% | 1.0 |
| MeVPLo2 (R) | 7 | ACh | 11.6 | 4.8% | 0.7 |
| MeVP9 (R) | 2 | ACh | 10.5 | 4.3% | 0.7 |
| MeTu1 (R) | 25 | ACh | 8.6 | 3.5% | 1.0 |
| Cm4 (R) | 21 | Glu | 7.8 | 3.2% | 0.8 |
| Mi4 (R) | 64 | GABA | 7.2 | 3.0% | 0.6 |
| Cm11d (R) | 7 | ACh | 6.7 | 2.7% | 0.9 |
| Cm5 (R) | 19 | GABA | 5.4 | 2.2% | 0.9 |
| Mi15 (R) | 40 | ACh | 5.4 | 2.2% | 0.6 |
| MeVPMe3 (R) | 1 | Glu | 5.2 | 2.1% | 0.0 |
| Cm10 (R) | 24 | GABA | 4.6 | 1.9% | 0.9 |
| MeVP12 (R) | 6 | ACh | 4 | 1.6% | 1.2 |
| Cm11a (R) | 9 | ACh | 3.7 | 1.5% | 0.6 |
| MeVP15 (R) | 11 | ACh | 2.2 | 0.9% | 0.8 |
| MeVP56 (R) | 1 | Glu | 2 | 0.8% | 0.0 |
| Dm4 (R) | 8 | Glu | 1.4 | 0.6% | 1.0 |
| Mi10 (R) | 14 | ACh | 1.4 | 0.6% | 0.7 |
| MeVPMe6 (R) | 1 | Glu | 1.2 | 0.5% | 0.0 |
| Tm5b (R) | 10 | ACh | 1.2 | 0.5% | 0.5 |
| R8d | 13 | HA | 1.1 | 0.5% | 1.0 |
| Dm8b (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| aMe5 (R) | 3 | ACh | 1 | 0.4% | 0.8 |
| Dm-DRA2 (R) | 6 | Glu | 0.8 | 0.3% | 0.5 |
| aMe9 (R) | 1 | ACh | 0.7 | 0.3% | 0.0 |
| Dm20 (R) | 7 | Glu | 0.7 | 0.3% | 0.5 |
| Mi16 (R) | 9 | GABA | 0.7 | 0.3% | 0.7 |
| TmY14 (R) | 6 | unc | 0.7 | 0.3% | 0.6 |
| Cm1 (R) | 3 | ACh | 0.6 | 0.3% | 0.6 |
| MeVP8 (R) | 3 | ACh | 0.6 | 0.3% | 0.6 |
| Cm11b (R) | 6 | ACh | 0.6 | 0.3% | 0.8 |
| Mi2 (R) | 8 | Glu | 0.6 | 0.2% | 0.3 |
| Tm5c (R) | 6 | Glu | 0.5 | 0.2% | 0.5 |
| Cm31b (R) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| Cm14 (R) | 5 | GABA | 0.5 | 0.2% | 0.5 |
| aMe12 (R) | 2 | ACh | 0.5 | 0.2% | 0.6 |
| R7d | 6 | HA | 0.5 | 0.2% | 0.3 |
| Cm30 (R) | 2 | GABA | 0.5 | 0.2% | 0.8 |
| Cm18 (R) | 2 | Glu | 0.4 | 0.2% | 0.5 |
| MeVP7 (R) | 2 | ACh | 0.4 | 0.2% | 0.1 |
| MeLo1 (R) | 2 | ACh | 0.4 | 0.2% | 0.4 |
| aMe4 (R) | 3 | ACh | 0.4 | 0.2% | 0.8 |
| MeTu2a (R) | 3 | ACh | 0.3 | 0.1% | 0.7 |
| C2 (R) | 5 | GABA | 0.3 | 0.1% | 0.3 |
| aMe26 (R) | 2 | ACh | 0.3 | 0.1% | 0.7 |
| Tm37 (R) | 2 | Glu | 0.3 | 0.1% | 0.6 |
| Mi1 (R) | 4 | ACh | 0.3 | 0.1% | 0.3 |
| Dm11 (R) | 4 | Glu | 0.3 | 0.1% | 0.3 |
| Tm3 (R) | 5 | ACh | 0.3 | 0.1% | 0.0 |
| Cm3 (R) | 5 | GABA | 0.3 | 0.1% | 0.0 |
| Tm5a (R) | 2 | ACh | 0.2 | 0.1% | 0.5 |
| MeVPMe5 (R) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| Tm29 (R) | 3 | Glu | 0.2 | 0.1% | 0.4 |
| L3 (R) | 3 | ACh | 0.2 | 0.1% | 0.4 |
| Tm30 (R) | 2 | GABA | 0.2 | 0.1% | 0.5 |
| Cm-DRA (R) | 2 | ACh | 0.2 | 0.1% | 0.0 |
| Cm22 (R) | 3 | GABA | 0.2 | 0.1% | 0.4 |
| Cm21 (R) | 3 | GABA | 0.2 | 0.1% | 0.4 |
| Tm26 (R) | 2 | ACh | 0.2 | 0.1% | 0.3 |
| MeTu3b (R) | 3 | ACh | 0.2 | 0.1% | 0.0 |
| Cm11c (R) | 2 | ACh | 0.2 | 0.1% | 0.3 |
| L5 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVP55 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Cm12 (R) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| T2 (R) | 2 | ACh | 0.1 | 0.0% | 0.0 |
| Tm6 (R) | 2 | ACh | 0.1 | 0.0% | 0.0 |
| Tm12 (R) | 2 | ACh | 0.1 | 0.0% | 0.0 |
| Tm4 (R) | 2 | ACh | 0.1 | 0.0% | 0.0 |
| Mi17 (R) | 2 | GABA | 0.1 | 0.0% | 0.0 |
| Dm10 (R) | 2 | GABA | 0.1 | 0.0% | 0.0 |
| Cm2 (R) | 2 | ACh | 0.1 | 0.0% | 0.0 |
| MeTu3a (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Dm12 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| TmY5a (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Dm15 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| TmY10 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| C3 (R) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| T1 (R) | 1 | HA | 0.1 | 0.0% | 0.0 |
| R8p | 1 | HA | 0.1 | 0.0% | 0.0 |
| TmY9a (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Tm1 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| TmY20 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Mi14 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Mi18 (R) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| Dm1 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Cm20 (R) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| Cm7 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeTu3c (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Dm8a (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Cm17 (R) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| MeVP45 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| aMe30 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeVP43 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVPMe2 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| L1 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeVPMe8 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeVC22 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Pm2b (R) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| Tm39 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVP59 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| aMe3 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Cm33 (R) | 1 | GABA | 0.1 | 0.0% | 0.0 |